Preview Until recently, vaginal candidiasis was generally managed with topical preparations, whereas trichomoniasis and bacterial vaginosis required systemic therapy. Now both topical and systemic therapies are available for vaginal candidiasis and bacterial vaginosis, although systemic therapy is still recommended for trichomoniasis. This article reviews considerations in selecting the most appropriate therapy, including drug efficacy, history of recurrence, ease of administration, and cost.
No takes yet. Share an insight, caveat, or question.
Goode et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: